Literature DB >> 30894317

Sonothrombolysis in ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention.

Wilson Mathias1, Jeane M Tsutsui1, Bruno G Tavares1, Agostina M Fava2, Miguel O D Aguiar1, Bruno C Borges1, Mucio T Oliveira1, Alexandre Soeiro1, Jose C Nicolau1, Henrique B Ribeiro1, Hsu Po Chiang1, João C N Sbano1, Abdulrahman Morad3, Andrew Goldsweig2, Carlos E Rochitte1, Bernardo B C Lopes1, José A F Ramirez1, Roberto Kalil Filho1, Thomas R Porter4.   

Abstract

BACKGROUND: Preclinical studies have demonstrated that high mechanical index (MI) impulses from a diagnostic ultrasound transducer during an intravenous microbubble infusion (sonothrombolysis) can restore epicardial and microvascular flow in acute ST-segment elevation myocardial infarction (STEMI).
OBJECTIVES: This study tested the clinical effectiveness of sonothrombolysis in patients with STEMI.
METHODS: Patients with their first STEMI were prospectively randomized to either diagnostic ultrasound-guided high MI impulses during an intravenous Definity (Lantheus Medical Imaging, North Billerica, Massachusetts) infusion before, and following, emergent percutaneous coronary intervention (PCI), or to a control group that received PCI only (n = 50 in each group). A reference first STEMI group (n = 203) who arrived outside the randomization window was also analyzed. Angiographic recanalization before PCI, ST-segment resolution, infarct size by magnetic resonance imaging, and systolic function (LVEF) at 6 months were compared.
RESULTS: ST-segment resolution occurred in 16 (32%) high MI PCI versus 2 (4%) PCI-only patients before PCI, and angiographic recanalization was 48% in high MI/PCI versus 20% in PCI only and 21% in the reference group (p < 0.001). Infarct size was reduced (29 ± 22 g high MI/PCI vs. 40 ± 20 g PCI only; p = 0.026). LVEF was not different between groups before treatment (44 ± 11% vs. 43 ± 10%), but increased immediately after PCI in the high MI/PCI group (p = 0.03), and remained higher at 6 months (p = 0.015). Need for implantable defibrillator (LVEF ≤30%) was reduced in the high MI/PCI group (5% vs. 18% PCI only; p = 0.045).
CONCLUSIONS: Sonothrombolysis added to PCI improves recanalization rates and reduces infarct size, resulting in sustained improvements in systolic function after STEMI. (Therapeutic Use of Ultrasound in Acute Coronary Artery Disease; NCT02410330).
Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  acute myocardial infarction; microbubbles; ultrasound

Mesh:

Substances:

Year:  2019        PMID: 30894317     DOI: 10.1016/j.jacc.2019.03.006

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  21 in total

1.  Sonoreperfusion therapy for microvascular obstruction: A step toward clinical translation.

Authors:  Filip Istvanic; Gary Z Yu; Francois T H Yu; Jeff Powers; Xucai Chen; John J Pacella
Journal:  Ultrasound Med Biol       Date:  2020-01-07       Impact factor: 2.998

Review 2.  Therapeutic Approach to Calcified Coronary Lesions: Disruptive Technologies.

Authors:  Keyvan Karimi Galougahi; Evan Shlofmitz; Allen Jeremias; Shawnbir Gogia; Ajay J Kirtane; Jonathan M Hill; Dimitri Karmpaliotis; Gary S Mintz; Akiko Maehara; Gregg W Stone; Richard A Shlofmitz; Ziad A Ali
Journal:  Curr Cardiol Rep       Date:  2021-03-05       Impact factor: 2.931

Review 3.  Contrast Ultrasound, Sonothrombolysis and Sonoperfusion in Cardiovascular Disease: Shifting to Theragnostic Clinical Trials.

Authors:  Soufiane El Kadi; Thomas R Porter; Niels J W Verouden; Albert C van Rossum; Otto Kamp
Journal:  JACC Cardiovasc Imaging       Date:  2021-10-13

4.  Sonothrombolysis Augments Reperfusion in ST-Elevation Myocardial Infarction With Primary Percutaneous Coronary Intervention: Insights From the SONOSTEMI Study.

Authors:  Kevin R Bainey; Ahmed Abulhamayel; Amir Aziz; Harald Becher
Journal:  CJC Open       Date:  2022-03-12

5.  Sonothrombolysis improves PCI after STEMI.

Authors:  Gregory B Lim
Journal:  Nat Rev Cardiol       Date:  2019-06       Impact factor: 32.419

6.  US-triggered Microbubble Destruction for Augmenting Hepatocellular Carcinoma Response to Transarterial Radioembolization: A Randomized Pilot Clinical Trial.

Authors:  John R Eisenbrey; Flemming Forsberg; Corinne E Wessner; Lauren J Delaney; Kristen Bradigan; Sriharsha Gummadi; Mohamed Tantawi; Andrej Lyshchik; Patrick O'Kane; Ji-Bin Liu; Charles Intenzo; Jesse Civan; Warren Maley; Scott W Keith; Kevin Anton; Allison Tan; Amanda Smolock; Susan Shamimi-Noori; Colette M Shaw
Journal:  Radiology       Date:  2020-12-15       Impact factor: 11.105

7.  Sonothrombolysis in the ambulance for ST-elevation myocardial infarction: rationale and protocol.

Authors:  S El Kadi; T R Porter; A C van Rossum; O Kamp
Journal:  Neth Heart J       Date:  2020-11-12       Impact factor: 2.380

8.  Augmentation of Tissue Perfusion with Contrast Ultrasound: Influence of Three-Dimensional Beam Geometry and Conducted Vasodilation.

Authors:  Matthew A Muller; Todd Belcik; James Hodovan; Koya Ozawa; Eran Brown; Jeffry Powers; Paul S Sheeran; Jonathan R Lindner
Journal:  J Am Soc Echocardiogr       Date:  2021-03-10       Impact factor: 7.722

9.  Flow Augmentation in the Myocardium by Ultrasound Cavitation of Microbubbles: Role of Shear-Mediated Purinergic Signaling.

Authors:  Federico Moccetti; Todd Belcik; Yllka Latifi; Aris Xie; Koya Ozawa; Eran Brown; Brian P Davidson; William Packwood; Azzdine Ammi; Sabine Huke; Jonathan R Lindner
Journal:  J Am Soc Echocardiogr       Date:  2020-06-10       Impact factor: 5.251

10.  Quantification of microbubble-induced sonothrombolysis in an ex vivo non-human primate model.

Authors:  Monica T Hinds; Azzdine Y Ammi; Jennifer Johnson; Sanjiv Kaul
Journal:  J Thromb Haemost       Date:  2020-12-23       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.